{"product_id":"ara-290","title":"ARA 290","description":"\u003cdetails open=\"\" style=\"margin-top: 30px; background: #05070A; border: 1px solid #605631; border-radius: 18px; overflow: hidden; font-family: Arial,sans-serif;\"\u003e\n\u003csummary style=\"padding: 28px; cursor: pointer; color: #ffffff; font-size: 26px; font-weight: 900; letter-spacing: 1px;\"\u003eARA 290 Research Protocol\u003c\/summary\u003e\n\u003cdiv style=\"padding: 32px; background: #131416; color: #f2f4f8; line-height: 1.8;\"\u003e\n\u003cp style=\"color: #caae54; text-transform: uppercase; letter-spacing: 3px; font-size: 13px; margin: 0 0 12px;\"\u003eNorthern Peptide Collective\u003c\/p\u003e\n\u003ch2 style=\"color: #ffffff; font-size: 40px; margin: 0 0 10px;\"\u003eARA 290\u003c\/h2\u003e\n\u003cp style=\"color: #ead48d; font-weight: 900; font-size: 22px; letter-spacing: 1px;\"\u003eCOMING SOON\u003c\/p\u003e\n\u003cp style=\"margin: 0 0 12px; color: #f2f4f8; line-height: 1.8;\"\u003eARA-290, also known as cibinetide, is an engineered peptide based on the helix B surface region of erythropoietin. It was developed to investigate tissue-protective signaling without the red-blood-cell-stimulating activity associated with erythropoietin.\u003c\/p\u003e\n\u003cdiv style=\"display: flex; flex-wrap: wrap; gap: 12px; margin: 24px 0;\"\u003e\n\u003cdiv style=\"background: #111820; border: 1px solid #35322a; border-radius: 12px; padding: 16px; min-width: 180px; flex: 1;\"\u003e\n\u003cstrong style=\"color: #ead48d; font-size: 13px;\"\u003eCompound\u003c\/strong\u003e\n\u003cp style=\"color: #f2f4f8; margin: 8px 0 0;\"\u003eARA-290 (cibinetide; helix B surface peptide)\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv style=\"background: #111820; border: 1px solid #35322a; border-radius: 12px; padding: 16px; min-width: 180px; flex: 1;\"\u003e\n\u003cstrong style=\"color: #ead48d; font-size: 13px;\"\u003eResearch Category\u003c\/strong\u003e\n\u003cp style=\"color: #f2f4f8; margin: 8px 0 0;\"\u003eErythropoietin-derived tissue-protective signaling research\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv style=\"background: #111820; border: 1px solid #35322a; border-radius: 12px; padding: 16px; min-width: 180px; flex: 1;\"\u003e\n\u003cstrong style=\"color: #ead48d; font-size: 13px;\"\u003eFormats\u003c\/strong\u003e\n\u003cp style=\"color: #f2f4f8; margin: 8px 0 0;\"\u003eSingle \/ 10 Pack\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv style=\"background: #111820; border: 1px solid #35322a; border-radius: 12px; padding: 16px; min-width: 180px; flex: 1;\"\u003e\n\u003cstrong style=\"color: #ead48d; font-size: 13px;\"\u003eAvailability\u003c\/strong\u003e\n\u003cp style=\"color: #f2f4f8; margin: 8px 0 0;\"\u003eCOMING SOON\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection style=\"margin: 22px 0; background: #111820; border: 1px solid #35322a; border-radius: 14px; padding: 22px;\"\u003e\n\u003ch3 style=\"color: #ead48d; font-size: 20px; margin: 0 0 12px;\"\u003eCompound Breakdown\u003c\/h3\u003e\n\u003cp style=\"margin: 0 0 12px; color: #f2f4f8; line-height: 1.8;\"\u003eCompound identity: ARA-290 (cibinetide; helix B surface peptide)\u003c\/p\u003e\n\u003cp style=\"margin: 0 0 12px; color: #f2f4f8; line-height: 1.8;\"\u003eResearch category: Erythropoietin-derived tissue-protective signaling research\u003c\/p\u003e\n\u003cp style=\"margin: 0 0 12px; color: #f2f4f8; line-height: 1.8;\"\u003eMechanistic focus: Innate repair \/ tissue-protective receptor signaling investigated in preclinical and early clinical research\u003c\/p\u003e\n\u003c\/section\u003e\n\u003csection style=\"margin: 22px 0; background: #111820; border: 1px solid #35322a; border-radius: 14px; padding: 22px;\"\u003e\n\u003ch3 style=\"color: #ead48d; font-size: 20px; margin: 0 0 12px;\"\u003eResearch Overview\u003c\/h3\u003e\n\u003cp style=\"margin: 0 0 12px; color: #f2f4f8; line-height: 1.8;\"\u003eARA-290, also known as cibinetide, is an engineered peptide based on the helix B surface region of erythropoietin. It was developed to investigate tissue-protective signaling without the red-blood-cell-stimulating activity associated with erythropoietin.\u003c\/p\u003e\n\u003c\/section\u003e\n\u003csection style=\"margin: 22px 0; background: #111820; border: 1px solid #35322a; border-radius: 14px; padding: 22px;\"\u003e\n\u003ch3 style=\"color: #ead48d; font-size: 20px; margin: 0 0 12px;\"\u003eResearch Focus\u003c\/h3\u003e\n\u003cul style=\"color: #f2f4f8; line-height: 1.9; padding-left: 22px;\"\u003e\n\u003cli\u003eSmall-fiber neuropathy clinical endpoints\u003c\/li\u003e\n\u003cli\u003eSarcoidosis-associated neuropathy studies\u003c\/li\u003e\n\u003cli\u003eCorneal nerve fiber measurements\u003c\/li\u003e\n\u003cli\u003eInflammatory and tissue-protective signaling\u003c\/li\u003e\n\u003cli\u003eNon-erythropoietic peptide pharmacology\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/section\u003e\n\u003csection style=\"margin: 22px 0; background: #111820; border: 1px solid #35322a; border-radius: 14px; padding: 22px;\"\u003e\n\u003ch3 style=\"color: #ead48d; font-size: 20px; margin: 0 0 12px;\"\u003ePublished Research \u0026amp; Evidence\u003c\/h3\u003e\n\u003cp style=\"margin: 0 0 12px; color: #f2f4f8; line-height: 1.8;\"\u003eSmall early-stage human studies examined neuropathic symptom scales and nerve-fiber measures. These findings are preliminary and require larger confirmatory trials.\u003c\/p\u003e\n\u003c\/section\u003e\n\u003csection style=\"margin: 22px 0; background: #111820; border: 1px solid #35322a; border-radius: 14px; padding: 22px;\"\u003e\n\u003ch3 style=\"color: #ead48d; font-size: 20px; margin: 0 0 12px;\"\u003eResearch Limitations\u003c\/h3\u003e\n\u003cp style=\"margin: 0 0 12px; color: #f2f4f8; line-height: 1.8;\"\u003eARA-290 has no broadly established approved therapeutic use or standard clinical regimen; early trial outcomes do not prove nerve repair or pain relief.\u003c\/p\u003e\n\u003c\/section\u003e\n\u003csection style=\"margin: 22px 0; background: #111820; border: 1px solid #35322a; border-radius: 14px; padding: 22px;\"\u003e\n\u003ch3 style=\"color: #ead48d; font-size: 20px; margin: 0 0 12px;\"\u003eVial Size Reference\u003c\/h3\u003e\n\u003ctable style=\"border-collapse: collapse; width: 100%; color: #f2f4f8;\"\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003cth style=\"text-align: left; border-bottom: 1px solid #605631; padding: 10px;\"\u003eFormat\u003c\/th\u003e\n\u003cth style=\"text-align: left; border-bottom: 1px solid #605631; padding: 10px;\"\u003eDetails\u003c\/th\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd style=\"padding: 10px;\"\u003eSingle\u003c\/td\u003e\n\u003ctd style=\"padding: 10px;\"\u003eOne vial; exact concentration to be confirmed\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd style=\"padding: 10px;\"\u003e10 Pack\u003c\/td\u003e\n\u003ctd style=\"padding: 10px;\"\u003eTen vials; exact concentration to be confirmed\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cp style=\"margin: 0 0 12px; color: #f2f4f8; line-height: 1.8;\"\u003eNo vial strength or concentration is asserted until the supplier confirms product specifications.\u003c\/p\u003e\n\u003c\/section\u003e\n\u003csection style=\"margin: 22px 0; background: #111820; border: 1px solid #35322a; border-radius: 14px; padding: 22px;\"\u003e\n\u003ch3 style=\"color: #ead48d; font-size: 20px; margin: 0 0 12px;\"\u003eQuality \u0026amp; Batch Documentation\u003c\/h3\u003e\n\u003cp style=\"margin: 0 0 12px; color: #f2f4f8; line-height: 1.8;\"\u003eBatch-specific certificates of analysis are available by request when issued for the relevant lot. Identity, purity, test methods and acceptance criteria must be confirmed for each batch.\u003c\/p\u003e\n\u003c\/section\u003e\n\u003csection style=\"margin: 22px 0; background: #111820; border: 1px solid #35322a; border-radius: 14px; padding: 22px;\"\u003e\n\u003ch3 style=\"color: #ead48d; font-size: 20px; margin: 0 0 12px;\"\u003eStorage Information\u003c\/h3\u003e\n\u003cp style=\"margin: 0 0 12px; color: #f2f4f8; line-height: 1.8;\"\u003eProduct-specific storage, stability and handling instructions will be provided after verification of the final formulation and batch documentation.\u003c\/p\u003e\n\u003c\/section\u003e\n\u003csection style=\"margin: 22px 0; background: #111820; border: 1px solid #35322a; border-radius: 14px; padding: 22px;\"\u003e\n\u003ch3 style=\"color: #ead48d; font-size: 20px; margin: 0 0 12px;\"\u003eFrequently Asked Questions\u003c\/h3\u003e\n\u003cp style=\"margin: 0 0 12px; color: #f2f4f8; line-height: 1.8;\"\u003eWhen is this product available? Coming soon; no launch date has been confirmed.\u003c\/p\u003e\n\u003cp style=\"margin: 0 0 12px; color: #f2f4f8; line-height: 1.8;\"\u003eCan it be ordered now? No. This product is listed as a draft and is not currently available for purchase.\u003c\/p\u003e\n\u003cp style=\"margin: 0 0 12px; color: #f2f4f8; line-height: 1.8;\"\u003eAre the listed research findings a recommended protocol? No. Published studies are scientific context, not product-specific administration guidance.\u003c\/p\u003e\n\u003c\/section\u003e\n\u003csection style=\"margin: 22px 0; background: #111820; border: 1px solid #35322a; border-radius: 14px; padding: 22px;\"\u003e\n\u003ch3 style=\"color: #ead48d; font-size: 20px; margin: 0 0 12px;\"\u003eResearch Reference\u003c\/h3\u003e\n\u003cbr\u003e\u003c\/section\u003e\n\u003cp style=\"color: #a5a7a9; font-size: 12px;\"\u003eScientific background is informational; product identity, regulatory eligibility, and batch specifications must be verified before publication.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/details\u003e","brand":"Northern Peptide Collective","offers":[{"title":"ARA-290-SINGLE","offer_id":47714094809260,"sku":"ARA-290-SINGLE","price":89.99,"currency_code":"CAD","in_stock":false},{"title":"ARA-290-10PACK","offer_id":47714094842028,"sku":"ARA-290-10PACK","price":649.99,"currency_code":"CAD","in_stock":false}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0784\/6651\/5116\/files\/NPC_APPROVED_9635703685292.png?v=1793552382","url":"https:\/\/www.northernpeptidecollective.ca\/products\/ara-290","provider":"NPC","version":"1.0","type":"link"}